Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.

Abstract

Carboplatin (CPT) and paclitaxel (PTX) used in combination is one of the most effective treatments for ovarian cancer. However, the traditional combination methods used to co-administrate CPT and PTX showed limited clinical efficacy due to their distinct pharmacokinetics. Although much effort has been devoted to developing nanoparticles capable of… (More)
DOI: 10.1039/c7ra01100h

Topics

9 Figures and Tables

Cite this paper

@article{Zhang2017CodeliveryOC, title={Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.}, author={Xiaoyang Zhang and Yarong Liu and Yu Jeong Kim and John Mac and Rachel Zhuang and Pin Wang}, journal={RSC advances}, year={2017}, volume={7 32}, pages={19685-19693} }